Last price paid | 1.20 | |
Change | +8.11% [ +0.09 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 19.07.2024 17:20 |
Fixing | n.a. |
Settlement date | 31.01.2024 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | +182.56% |
Year to date (YTD) | n.a. |
1 month | -25.00% |
3 months | +13.21% |
1 year | n.a. |
3 years | n.a. |
Issue price | 0.43 |
Underlying price on issue | 745.70 |
Premium | 0.01% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1305134277 |
Symbol | INOLQZ |
Security | 130513427 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | Novo Nordisk -B-, DK0062498333 |
Underlying ISIN | DK0062498333 |
Funding level | 682.077900 |
Stop-loss level | 706.305100 |
Distance to stop-loss level | 22.33% |
Long/Short type | Long |
Subscription ratio | 25.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 29.01.2024 |
Premium | 0.75% |
Premium p.a. | n.a. |
Leverage | 3.88 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 227.322100 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
KUEHNE & NAGEL | 265.00 |
NOVARTIS N | 96.36 |
LOGITECH INT. | 80.58 |
Givaudan | 4'306.00 |
Swiss Life Hldg | 678.40 |
Name | Price |
---|---|
Swiss Re | 106.15 |
ZURICH INSURANCE | 474.30 |
ROCHE GS | 279.60 |
Alcon AG | 80.42 |
SWISSCOM N | 535.00 |